Strategies for harmonization of next generation oncology drug development: a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam [u.a.]
Elsevier
2007
|
| Ausgabe: | [Bindeeinheit] |
| Schriftenreihe: | EJC
Supplements ; 5,9 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 52 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV023071573 | ||
| 003 | DE-604 | ||
| 005 | 20080327 | ||
| 007 | t| | ||
| 008 | 080109s2007 xx d||| |||| 10||| eng d | ||
| 035 | |a (OCoLC)634284868 | ||
| 035 | |a (DE-599)BVBBV023071573 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-29 |a DE-19 |a DE-20 | ||
| 245 | 1 | 0 | |a Strategies for harmonization of next generation oncology drug development |b a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria |c guest ed.: Heinz Zwierzina ... |
| 250 | |a [Bindeeinheit] | ||
| 264 | 1 | |a Amsterdam [u.a.] |b Elsevier |c 2007 | |
| 300 | |a 52 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a EJC : Supplements |v 5,9 | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2007 |z Innsbruck |2 gnd-content | |
| 689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Zwierzina, Heinz |e Sonstige |4 oth | |
| 830 | 0 | |a EJC |v Supplements ; 5,9 |w (DE-604)BV017615175 |9 5,9 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016274718&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-016274718 | |
Datensatz im Suchindex
| _version_ | 1823607503055749120 |
|---|---|
| adam_text |
Contents
Strategies for Harmonization of Next-Generation Oncology Drug
Development
Guest Editors: Heinz Zwierzina, Lothar Bergmann, Anne deBock, Steuen Hirsch/eld
Introduction 1
H. Zu/ierzina and M. Ellis
Pharmacoeconomics behind next-generation oncology drug development 2
H. Zwiemna,}. Liliemarfe and A. deBocfe
Biomarkers and translational research 10
V. Nuessler, P. Demolis and S. Schuroch
Upcoming techniques in drug development 18
A. Hoos and H. Lindner
Progression-free survival as an end-point in clinical trials of biotherapeutic agents 23
L Bergmann, S. Hirsch/eld, C. Morris, S. Palmeri and A. Stone, Biotherapy Development Association (BDA)
Vaccines: A rapidly evolving technology - Are the hurdles being addressed? 29
L. Hdfeansson, A. Dalgleish, KJ. Kallen and M. Schuessler-Lenz
Tissue collection in drug discovery and development research 33
C. Womack and G. Clack
How can biomarkers become surrogate endpoints? 37
B. Berns, P. Demolis and M.E. Scheulen
Clinical trial design issues - Session 1 41
R. Milsted, T. Hinz and C.C. Zielinski
Clinical trial design issues - Session 2 46
H.X. Chen, A. Tinetti and H. Ziuierzina |
| adam_txt |
Contents
Strategies for Harmonization of Next-Generation Oncology Drug
Development
Guest Editors: Heinz Zwierzina, Lothar Bergmann, Anne deBock, Steuen Hirsch/eld
Introduction 1
H. Zu/ierzina and M. Ellis
Pharmacoeconomics behind next-generation oncology drug development 2
H. Zwiemna,}. Liliemarfe and A. deBocfe
Biomarkers and translational research 10
V. Nuessler, P. Demolis and S. Schuroch
Upcoming techniques in drug development 18
A. Hoos and H. Lindner
Progression-free survival as an end-point in clinical trials of biotherapeutic agents 23
L Bergmann, S. Hirsch/eld, C. Morris, S. Palmeri and A. Stone, Biotherapy Development Association (BDA)
Vaccines: A rapidly evolving technology - Are the hurdles being addressed? 29
L. Hdfeansson, A. Dalgleish, KJ. Kallen and M. Schuessler-Lenz
Tissue collection in drug discovery and development research 33
C. Womack and G. Clack
How can biomarkers become surrogate endpoints? 37
B. Berns, P. Demolis and M.E. Scheulen
Clinical trial design issues - Session 1 41
R. Milsted, T. Hinz and C.C. Zielinski
Clinical trial design issues - Session 2 46
H.X. Chen, A. Tinetti and H. Ziuierzina |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV023071573 |
| ctrlnum | (OCoLC)634284868 (DE-599)BVBBV023071573 |
| edition | [Bindeeinheit] |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV023071573</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080327</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">080109s2007 xx d||| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)634284868</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023071573</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Strategies for harmonization of next generation oncology drug development</subfield><subfield code="b">a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria</subfield><subfield code="c">guest ed.: Heinz Zwierzina ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">[Bindeeinheit]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam [u.a.]</subfield><subfield code="b">Elsevier</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">52 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">EJC : Supplements</subfield><subfield code="v">5,9</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2007</subfield><subfield code="z">Innsbruck</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zwierzina, Heinz</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">EJC</subfield><subfield code="v">Supplements ; 5,9</subfield><subfield code="w">(DE-604)BV017615175</subfield><subfield code="9">5,9</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016274718&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016274718</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2007 Innsbruck gnd-content |
| genre_facet | Konferenzschrift 2007 Innsbruck |
| id | DE-604.BV023071573 |
| illustrated | Illustrated |
| index_date | 2024-07-02T19:33:13Z |
| indexdate | 2025-02-09T19:00:38Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016274718 |
| oclc_num | 634284868 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-29 DE-19 DE-BY-UBM DE-20 |
| owner_facet | DE-355 DE-BY-UBR DE-29 DE-19 DE-BY-UBM DE-20 |
| physical | 52 S. graph. Darst. |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | Elsevier |
| record_format | marc |
| series | EJC |
| series2 | EJC : Supplements |
| spelling | Strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria guest ed.: Heinz Zwierzina ... [Bindeeinheit] Amsterdam [u.a.] Elsevier 2007 52 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier EJC : Supplements 5,9 Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2007 Innsbruck gnd-content Cytostatikum (DE-588)4068347-3 s Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Zwierzina, Heinz Sonstige oth EJC Supplements ; 5,9 (DE-604)BV017615175 5,9 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016274718&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria EJC Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4068347-3 (DE-588)1071861417 |
| title | Strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria |
| title_auth | Strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria |
| title_exact_search | Strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria |
| title_exact_search_txtP | Strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria |
| title_full | Strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria guest ed.: Heinz Zwierzina ... |
| title_fullStr | Strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria guest ed.: Heinz Zwierzina ... |
| title_full_unstemmed | Strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria guest ed.: Heinz Zwierzina ... |
| title_short | Strategies for harmonization of next generation oncology drug development |
| title_sort | strategies for harmonization of next generation oncology drug development a report from the third alpine meeting of the biotherapy development association bda 2007 14 16 march 2007 innsbruck austria |
| title_sub | a report from the third alpine meeting of the Biotherapy Development Association (BDA 2007), 14 - 16 March 2007, Innsbruck, Austria |
| topic | Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd |
| topic_facet | Arzneimittelentwicklung Cytostatikum Konferenzschrift 2007 Innsbruck |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016274718&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV017615175 |
| work_keys_str_mv | AT zwierzinaheinz strategiesforharmonizationofnextgenerationoncologydrugdevelopmentareportfromthethirdalpinemeetingofthebiotherapydevelopmentassociationbda20071416march2007innsbruckaustria |